Murray Income Trust: a rare star in the income sector
The Murray Income Trust is a reliable and promising pick in a struggling sector.
In the second quarter of 2020 dividends paid by UK companies fell by 57%. Just a quarter of dividend-paying constituents of the FTSE 350 maintained or increased payments. For the year as a whole, dividends paid by FTSE 100 firms are forecast to be 32% lower than last year.
As a result, the UK equity income section of the funds market has become something of a graveyard, with many five-year performances negative. The sector’s fall from grace has been exacerbated by the exaggerated expectations of the past, based on a combination of the hunt for income in a world of falling bond yields and interest rates, and a misunderstanding of the pattern of historic returns.
Misinterpreting history
Many commentators emphasised the importance of reinvested income to long-term returns, from which they jumped to the non sequitur that investing for income was the way to maximise returns. The flaws in this idea are firstly that investors can’t benefit from compounding if the income is not reinvested. Secondly, the benefit of compounding comes from extracting the income of mature, high-yielding investments and reinvesting it not in the same companies, but in immature growth companies.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Nevertheless, the flood of money into high-yielding shares encouraged managements to pay unsustainable dividends, pushed up share prices and created the illusion of success for many years before it ran out of momentum. As the Neil Woodford debacle showed, the tide was going out for income investing long before the pandemic struck.
Many income-fund managers crowded into the same high-yielding stocks, notably Shell, HSBC and Vodafone. But the shrewder ones focused on companies with moderate but growing yields, rather than high but static ones. Notable among these are Charles Luke and Iain Pyle, managers of the £530m Murray Income Trust (LSE: MUT). Full disclosure: MoneyWeek’s editor-in-chief, Merryn Somerset Webb, sits on the board).
Its shares have returned 30% over five years (far ahead of the FTSE All Share’s 8.5%), trade on a 5% discount to net asset value, but still yield 4.7%. Luke emphasises the importance of “high-quality companies with strong competitive positions, robust financial characteristics and experienced management.
Diversification is helped by having up to 20% of the portfolio listed overseas, a broad range of companies and the avoidance of exposure to any one economic scenario”. The top-20 investments include no banks, no oil majors other than Total (no 16), no Vodafone and no retailers.
Betting on long-term growth
More importantly, the portfolio has barely changed since the start of the year. There has been little or no whitewashing by disposing of embarrassing mistakes.
With companies such as Diageo, Aveva, Unilever and RELX in the top ten, long-term growth is well represented. Healthcare comprises 15% of the portfolio (AstraZeneca, GlaxoSmithKline and Roche). Murray has large holdings in BHP and Rio Tinto.
With a solid record and a sensible portfolio, it is not surprising that Murray Income has been chosen by the directors of Perpetual Income & Growth Investment Trust, the troubled trust previously managed by Invesco, as its merger partner. This should result in cost savings for Murray Income and provide new investors with an opportunity to buy at an attractive price.
UK equity income won’t return to its previous level of popularity, but rumours of its death have been exaggerated. The UK faces significant uncertainties, but valuations of quality British equities were low in absolute and relative terms before the crisis and are even cheaper now. Having ridden the down cycle better than most rivals, Murray Income should profit from the upswing.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published
-
TSB fined £10.9 million over ‘woeful systems and controls’ for struggling customers
News The Financial Conduct Authority issued the fine for historic failings by TSB after mortgage, loan and credit card customers were treated unfairly
By Marc Shoffman Published
-
Is China an undervalued market?
Most funds remain wary of China amid slowing growth. Have they got it wrong?
By Max King Published
-
A fairer deal for investment trusts
New rules on how investment trusts report costs should ditch the idea that investors only need to look at one number
By Cris Sholto Heaton Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
After Priips changes, investment trusts are due a rerating
Heavy-handed rules governing fees, which put investment trust companies at a disadvantage, are to go.
By Rupert Hargreaves Published
-
Top trusts that offer growth at a discount
Professional investor Alastair Laing picks three trusts where he'd put his money
By Alastair Laing Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published